Handbook of Multiple Comparisons

 
Kiadás sorszáma: 1
Kiadó: Chapman and Hall
Megjelenés dátuma:
 
Normál ár:

Kiadói listaár:
GBP 76.99
Becsült forint ár:
37 186 Ft (35 415 Ft + 5% áfa)
Miért becsült?
 
Az Ön ára:

29 749 (28 332 Ft + 5% áfa )
Kedvezmény(ek): 20% (kb. 7 437 Ft)
A kedvezmény érvényes eddig: 2024. június 30.
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
 
Beszerezhetőség:

Becsült beszerzési idő: A Prosperónál jelenleg nincsen raktáron, de a kiadónál igen. Beszerzés kb. 3-5 hét..
A Prosperónál jelenleg nincsen raktáron.
Nem tudnak pontosabbat?
 
  példányt

 
Rövid leírás:

Treats the topics of multiple comparisons, simultaneous and selective inference from avariety of different perspectives. The need for a systematic treatment of the eld originates from the relevanceof multiple comparisons in many applications (medicine, industry, economics), and from the diversityof approaches and developments.

Hosszú leírás:

Written by experts that include originators of some key ideas, chapters in the Handbook of Multiple Testing cover multiple comparison problems big and small, with guidance toward error rate control and insights on how principles developed earlier can be applied to current and emerging problems. Some highlights of the coverages are as follows.


Error rate control is useful for controlling the incorrect decision rate. Chapter 1 introduces Tukey's original multiple comparison error rates and point to how they have been applied and adapted to modern multiple comparison problems as discussed in the later chapters.


Principles endure. While the closed testing principle is more familiar, Chapter 4 shows the partitioning principle can derive confidence sets for multiple tests, which may become important as the profession goes beyond making decisions based on p-values.


Multiple comparisons of treatment efficacy often involve multiple doses and endpoints. Chapter 12 on multiple endpoints explains how different choices of endpoint types lead to different multiplicity adjustment strategies, while Chapter 11 on the MCP-Mod approach is particularly useful for dose-finding. To assess efficacy in clinical trials with multiple doses and multiple endpoints, the reader can see the traditional approach in Chapter 2, the Graphical approach in Chapter 5, and the multivariate approach in Chapter 3.


Personalized/precision medicine based on targeted therapies, already a reality, naturally leads to analysis of efficacy in subgroups. Chapter 13 draws attention to subtle logical issues in inferences on subgroups and their mixtures, with a principled solution that resolves these issues. This chapter has implication toward meeting the ICHE9R1 Estimands requirement.


Besides the mere multiple testing methodology itself, the handbook also covers related topics like the statistical task of model selection in Chapter 7 or the estimation of the proportion of true null hypotheses (or, in other words, the signal prevalence) in Chapter 8. It also contains decision-theoretic considerations regarding the admissibility of multiple tests in Chapter 6. The issue of selected inference is addressed in Chapter 9.


Comparison of responses can involve millions of voxels in medical imaging or SNPs in genome-wide association studies (GWAS). Chapter 14 and Chapter 15 provide state of the art methods for large scale simultaneous inference in these settings.


 


Tartalomjegyzék:

1. An Overview of Multiple Comparisons. 2. Multiple Test Procedures Based on p-Values. 3. Multivariate multiple test procedures. 4. Partitioning for Confidence Sets, Confident Directions, and Decision Paths. 5. Graphical approaches for multiple comparison procedures. 6. Decision Theoretic Considerations of Multiple Comparisons. 7 Identifying important predictors in large data bases - multiple testing and model selection. 8. Prevalence Estimation. 9. On agnostic post hoc approaches to false positive control. 10. Group sequential and adaptive designs. 11. Multiple testing for dose finding. 12. Multiple Endpoints. 13. Subgroups Analysis for Personalized and Precision Medicine Development. 14. Exploratory inference: localizing relevant effects with confidence. 15. Testing SNPs in Targeted Drug Development.